OFFICIAL NOTICE – UNIVERSITY OF GHANA MEDICAL SCHOOL

The University of Ghana Medical School (UGMS) wishes to categorically state that a publication currently circulating on social media claiming that UGMS researchers have developed a cassava-based compound (“cassavarin”) that reverses Type 2 diabetes is entirely false.

UGMS has not conducted any such study, has not isolated any compound by that name, and has not undertaken clinical trials of the nature described. The claims regarding regulatory approvals, pharmaceutical lawsuits, and licensing are fabricated.

The University of Ghana Medical School maintains the highest standards of scientific integrity and ethical research practice. Members of the public are advised to rely only on information released through official University of Ghana channels.

UGMS strongly dissociates itself from this misinformation and is taking appropriate steps to address the matter.

Signed:

[Dean, UGMS]